News

Operational metrics from the initial clinical trials that have been deployed using TrialTracker™ have met or exceeded all expectations for performance.

The first malaria vaccine candidate (RTS,S/AS01) to reach Phase 3 trials is partially effective against clinical disease in young African children up to four years after vaccination, according to final trial data published in The Lancet, which will now be evaluated by the European Medicines Agency (EMA).

INC Research announced a strategic collaboration with DrugDev to complete integration with and implementation of DrugDev’s SiteCloud platform.

Combined solution can help identify trial risks in operational and clinical data before traditional methods.

Accenture has expanded its Accenture Life Sciences Cloud for Research and Development (R&D) powered by Oracle with the addition of enhanced clinical data management capabilities.

Since its inception in early 2014, the SAG initiative has exercised considerable impact on the clinical research landscape by inciting important dialogue between site professionals and industry leaders related to current and evolving practices.

The ACTA was initiated in 2012 by the National Center for Advancing Translational Sciences (NCATS) through its Clinical and Translational Science Awards program in collaboration with representatives from several pharmaceutical companies to facilitate negotiations between institutional research sites and industry sponsors.

PPD has opened a central laboratory in Shanghai, China, to meet growing scientific and technical laboratory client demand for these services in China.

Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, announced that it has received a project grant as part of a consortium.

The shift from volume- to performance-based payment is propelling life sciences companies to seek concrete data and medical evidence – both to understand patient care and to demonstrate the effectiveness, safety and value of drug therapies.

INC Research announced the formation of a new Site Advocacy Group (SAG) under the auspices of its relationship with the Society for Clinical Research Sites (SCRS).

Quintiles announced a strategic alliance with Hospital Italiano of Buenos Aires as part of the company’s Prime Site program.

ERT announced the launch of the Insights Cloud™, a suite of data analytics, visualization, and workflow applications.

New faces among the Pharma Industry rise the ranks.

Figure 1: The Problem